Cargando…

The European response to the WHO call to eliminate cervical cancer as a public health problem

The age‐standardised incidence of cervical cancer in Europe varies widely by country (between 3 and 25/100000 women‐years) in 2018. Human papillomavirus (HPV) vaccine coverage is low in countries with the highest incidence and screening performance is heterogeneous among European countries. A broad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arbyn, Marc, Gultekin, Murat, Morice, Philippe, Nieminen, Pekka, Cruickshank, Maggie, Poortmans, Philip, Kelly, Daniel, Poljak, Mario, Bergeron, Christine, Ritchie, David, Schmidt, Dietmar, Kyrgiou, Maria, Van den Bruel, Ann, Bruni, Laia, Basu, Partha, Bray, Freddie, Weiderpass, Elisabete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754400/ https://www.ncbi.nlm.nih.gov/pubmed/32638362 http://dx.doi.org/10.1002/ijc.33189

Ejemplares similares

Tackling cervical cancer in Europe amidst the COVID-19 pandemic
por: Arbyn, Marc, et al.
Publicado: (2020)

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
por: Arbyn, Marc, et al.
Publicado: (2019)

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
por: Kyrgiou, Maria, et al.
Publicado: (2020)

European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic
por: Ciavattini, Andrea, et al.
Publicado: (2020)

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative
por: Singh, Deependra, et al.
Publicado: (2022)

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
por: Taumberger, Nadja, et al.
Publicado: (2022)

Europe's Path to Eliminating Cervical Cancer as a Public Health Problem
por: Ritchie, David, et al.
Publicado: (2021)

An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme
por: Zhang, Li, et al.
Publicado: (2022)

Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000–19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4
por: Bray, Freddie, et al.
Publicado: (2021)

Inequities in cancer outcomes
por: Ali, Mohamed El Amine Youcef, et al.
Publicado: (2023)

Cervical cancer screening programmes and policies in 18 European countries
por: Anttila, A, et al.
Publicado: (2004)

Fostering Prevention of Cervical Cancer by a Correct Diagnosis of Precursors: A Structured Case-Based Colposcopy Course in Finland, Norway and UK
por: Sabrina, Forsell, et al.
Publicado: (2020)

Role of Colposcopy after Treatment for Cervical Intraepithelial Neoplasia
por: Heinonen, Annu, et al.
Publicado: (2020)

Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis
por: Mena, Marisa, et al.
Publicado: (2019)

Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature
por: Kalliala, I., et al.
Publicado: (2020)

Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
por: Bruni, Laia, et al.
Publicado: (2023)

Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
por: Arbyn, Marc, et al.
Publicado: (2022)

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study
por: Vaccarella, Salvatore, et al.
Publicado: (2016)

Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis
por: Kyrgiou, Maria, et al.
Publicado: (2014)

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia
por: Kesic, Vesna, et al.
Publicado: (2023)

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia
por: Kesic, Vesna, et al.
Publicado: (2023)

Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland
por: Weiderpass, Elisabete, et al.
Publicado: (2006)

Malignant Tumors of the Female Reproductive System
por: Weiderpass, Elisabete, et al.
Publicado: (2012)

Alcohol as a Risk Factor for Cancer: Existing Evidence in a Global Perspective
por: Roswall, Nina, et al.
Publicado: (2015)

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
por: Xu, Lan, et al.
Publicado: (2018)

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
por: Arbyn, M, et al.
Publicado: (2008)

Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
por: Kyrgiou, Maria, et al.
Publicado: (2016)

Risk Factors for Breast Cancer, Including Occupational Exposures
por: Weiderpass, Elisabete, et al.
Publicado: (2011)

Socioeconomic differences in cancer survival: The Norwegian Women and Cancer Study
por: Braaten, Tonje, et al.
Publicado: (2009)

Present and future of health inequalities: Rationale for investing in the biological capital
por: Vaccarella, Salvatore, et al.
Publicado: (2020)

Prevention is life- and cost-saving
por: Baussano, Iacopo, et al.
Publicado: (2020)

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2021)

Cervical cancer programme, Kenya, 2011–2020: lessons to guide elimination as a public health problem
por: Mwenda, Valerian, et al.
Publicado: (2022)

Population attributable fractions continue to unmask the power of prevention
por: Bray, Freddie, et al.
Publicado: (2018)

Population-based cancer registries: a gateway to improved surveillance of non-communicable diseases
por: Mery, Les, et al.
Publicado: (2020)

Including refugees in disease elimination: challenges observed from a sleeping sickness programme in Uganda
por: Palmer, Jennifer J., et al.
Publicado: (2017)

Knowledge, attitudes and practices on cervical cancer screening among the medical workers of Mulago Hospital, Uganda
por: Mutyaba, Twaha, et al.
Publicado: (2006)

Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis
por: Kechagias, Konstantinos S, et al.
Publicado: (2022)

Global Cancer Inequalities
por: Fidler, Miranda M., et al.
Publicado: (2018)

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
por: Xia, Changfa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_06ebmurhd8d5s85ldfjg5er0ms